Yu-San Chen

Title: The Innovations of Yu-San Chen

Introduction

Yu-San Chen is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for porcine diseases. His work has implications for improving animal health and productivity in the swine industry.

Latest Patents

Yu-San Chen holds a patent for a porcine circovirus type-2 (PCV2) subunit vaccine. This immunogenic composition includes an antigenic peptide that is a non-arginine-rich peptide derived from the PCV2 open reading frame 2 (ORF2). The innovative aspect of this vaccine lies in its formulation, which includes a recombinant fusion protein that combines the non-arginine-rich peptide, a PE peptide, and a KDEL signal peptide. The design ensures that the number of arginines in the non-arginine-rich peptide does not exceed half of those in the arginine-rich domain of the N terminal of the PCV2 ORF2.

Career Highlights

Yu-San Chen is associated with Sbc Virbac Limited, where he continues to advance his research and development efforts. His work is pivotal in addressing the challenges posed by porcine circovirus infections, which can have devastating effects on swine health and the agricultural economy.

Collaborations

Throughout his career, Yu-San Chen has collaborated with esteemed colleagues such as Tsun-Yung Kuo and Hsu-Chung Gabriel Chen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yu-San Chen's contributions to veterinary medicine, particularly through his patented vaccine for porcine circovirus type-2, highlight his role as an influential inventor in the field. His work not only advances scientific knowledge but also supports the health and productivity of swine populations.